Literature DB >> 8428389

Macrophage depletion decreases IgG anti-DNA in cultures from (NZB x NZW)F1 spleen cells by eliminating the main source of IL-6.

M E Alarcón-Riquelme1, G Möller, C Fernández.   

Abstract

We have studied the role of macrophages in the production of IgG anti-DNA autoantibodies by (NZB x NZW)F1 mice (B/W). One of the main features of the systemic lupus erythematosus (SLE)-like disease that affects these mice, is the presence of circulating IgG autoantibodies and immune complexes, which lead to renal failure and death by the age of 8-9 months. IgG autoantibodies are produced without in vitro stimulation by total spleen cells from these mice when they reach the age of 6 months. We have demonstrated that IL-6 increases the production of IgG autoantibodies in cultures of splenic purified B cells from the old B/W mice. The aim of this study was to show the involvement of macrophages in the production of IL-6 and consequently in the production of IgG anti-DNA antibodies in vitro. We show that elimination of the macrophages by different treatments led to reduction of the content of IL-6 in the supernatants as well as of IgG anti-DNA autoantibodies. Addition of fresh, splenic or peritoneal macrophages restored the production of autoantibodies in macrophage-depleted cultures from old B/W mice. There were no differences in the capacity of IL-6 production between macrophages from old or young B/W mice, but an important difference was observed between peritoneal and splenic macrophages, where the former produced much higher levels of IL-6, and consequently were more potent inducers of IgG autoantibodies. The present results reinforce the role of macrophages and IL-6 in the production of IgG anti-DNA autoantibodies in B/W mice. The implications of these results in the pathogenesis of the disease are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8428389      PMCID: PMC1554691          DOI: 10.1111/j.1365-2249.1993.tb05886.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

Review 1.  Interleukin-6 and its relation to inflammation and disease.

Authors:  T Hirano
Journal:  Clin Immunol Immunopathol       Date:  1992-01

Review 2.  Inflammatory cytokines: interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases.

Authors:  C A Dinarello
Journal:  Curr Opin Immunol       Date:  1991-12       Impact factor: 7.486

Review 3.  Murine models of systemic lupus erythematosus.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Adv Immunol       Date:  1985       Impact factor: 3.543

4.  Evidence implicating L3T4 in class II MHC antigen reactivity; monoclonal antibody GK1.5 (anti-L3T4a) blocks class II MHC antigen-specific proliferation, release of lymphokines, and binding by cloned murine helper T lymphocyte lines.

Authors:  D B Wilde; P Marrack; J Kappler; D P Dialynas; F W Fitch
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

5.  Macrophages are required for the dextran-sulfate induced activation of B lymphocytes.

Authors:  U C Persson; L L Hammarström; C I Smith
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

6.  Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: delineation by its sensitivity to the lysosomotropic agent, L-leucine methyl ester.

Authors:  D L Thiele; M Kurosaka; P E Lipsky
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

7.  A synergistic polyclonal response to dextran sulphate and lipopolysaccharide: immunoglobulin secretion and cell requirements.

Authors:  S Bergstedt-Lindqvist; C Fernandez; E Severinson
Journal:  Scand J Immunol       Date:  1981-05       Impact factor: 3.487

8.  Properties and applications of monoclonal antibodies directed against determinants of the Thy-1 locus.

Authors:  A Marshak-Rothstein; P Fink; T Gridley; D H Raulet; M J Bevan; M L Gefter
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

9.  Intracellular disruption of rat heart lysosomes by leucine methyl ester: effects on protein degradation.

Authors:  J P Reeves; R S Decker; J S Crie; K Wildenthal
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

10.  Modulation of human natural killer cell function by L-leucine methyl ester: monocyte-dependent depletion from human peripheral blood mononuclear cells.

Authors:  D L Thiele; P E Lipsky
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

View more
  14 in total

Review 1.  Tumour necrosis factor and other cytokines in murine lupus.

Authors:  A N Theofilopoulos; B R Lawson
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

2.  IL-6 increases B-cell IgG production in a feed-forward proinflammatory mechanism to skew hematopoiesis and elevate myeloid production.

Authors:  Kenichiro Maeda; Harshini Mehta; Douglas A Drevets; K Mark Coggeshall
Journal:  Blood       Date:  2010-03-29       Impact factor: 22.113

3.  Separate checkpoints regulate splenic plasma cell accumulation and IgG autoantibody production in Lyn-deficient mice.

Authors:  Toni Gutierrez; Kristina E Halcomb; Alanna J Coughran; Quan-Zhen Li; Anne B Satterthwaite
Journal:  Eur J Immunol       Date:  2010-07       Impact factor: 5.532

Review 4.  The role of cytokines in the immunopathogenesis of lupus.

Authors:  B S Handwerger; V Rus; L da Silva; C S Via
Journal:  Springer Semin Immunopathol       Date:  1994

5.  Influence of cholecalciferol (vitamin D3) on the course of experimental systemic lupus erythematosus in F1 (NZBxW) mice.

Authors:  M W Vaisberg; R Kaneno; M F Franco; N F Mendes
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

6.  Deficiency in IRAK4 activity attenuates manifestations of murine Lupus.

Authors:  Michael Murphy; Goutham Pattabiraman; Tissa T Manavalan; Andrei E Medvedev
Journal:  Eur J Immunol       Date:  2017-03-31       Impact factor: 5.532

7.  Cytokine-induced monocyte characteristics in SLE.

Authors:  Zhe Zhang; Kelly Maurer; Juan C Perin; Li Song; Kathleen E Sullivan
Journal:  J Biomed Biotechnol       Date:  2010-06-24

8.  Interleukin 6 promotes murine lupus in NZB/NZW F1 mice.

Authors:  B K Finck; B Chan; D Wofsy
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

Review 9.  Rationale for interleukin-6 blockade in systemic lupus erythematosus.

Authors:  E Tackey; P E Lipsky; G G Illei
Journal:  Lupus       Date:  2004       Impact factor: 2.911

10.  Interleukin-6 aborts lymphopoiesis and elevates production of myeloid cells in systemic lupus erythematosus-prone B6.Sle1.Yaa animals.

Authors:  Kenichiro Maeda; Alex Malykhin; Brittany N Teague-Weber; Xiao-Hong Sun; A Darise Farris; K Mark Coggeshall
Journal:  Blood       Date:  2009-02-17       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.